Keyphrases
B Cells
100%
Rheumatoid Arthritis
100%
Mechanistic Insight
100%
Rheumatoid Factor
25%
Autoimmune Disease
25%
Autoantibodies
25%
Clinical Manifestations
12%
Illness
12%
Biological Markers
12%
New Evidence
12%
Inflammatory Disorders
12%
Cell Complex
12%
Pathogenic Role
12%
Rituximab
12%
Rheumatoid Arthritis Patients
12%
Independent Functions
12%
Bone Damage
12%
Tendon Injury
12%
Targeted Compounds
12%
Cartilage Injury
12%
Severe Inflammation
12%
Therapeutic Outcome
12%
Related Conditions
12%
B Lymphocytes
12%
Arthritis Treatment
12%
Treatment Evidence
12%
Immune Tolerance
12%
Anti-B Cell Therapy
12%
B Cell-targeted Therapy
12%
Targeted Therapy
12%
Anti-cyclic Citrullinated Peptide Antibody (anti-CCP)
12%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Inflammatory Arthritis
100%
Disease
50%
Rheumatoid Factor
50%
Autoimmune Disease
50%
Autoantibodies
50%
Inflammation
25%
Infection
25%
Biological Marker
25%
Arthritis
25%
Rituximab
25%
Cyclic Citrullinated Peptide Antibody
25%
Bone Injury
25%
Immunology and Microbiology
B Cell
100%
Inflammatory Arthritis
100%
Rheumatoid Factor
18%
Autoimmune Disease
18%
Autoantibodies
18%
Inflammatory Disorder
9%
Immune Tolerance
9%
Arthritis
9%
Cartilage
9%
Rituximab
9%
Anti-Citrullinated Protein Antibody
9%
Immunology
9%